Pluristem Therapeutics receives patent in India Pluristem Therapeutics announced it has been granted Patent No. 261087 from India's Office of the Controller General of Patents, Designs & Trade Marks for a patent titled, "Methods for Cell Expansion and Conditioned Media Produced Thereby for Therapy." The patent, which has also been granted to Pluristem in Australia, Russia and South Africa, covers the company's key technology platform, its method for 3-dimensional expansion of placental and adipose derived cells. It also covers the composition of cells derived using this method.
Piper Jaffray and the Alliance for Regenerative Medicine co-host conference 3rd Annual Regenerative Medicine Investor Day is being held in New York on March 25 with webcasted company presentations to begin at 8 am; not all company presentations may be webcasted. Webcast Link